NCBiotech Company Directory is a comprehensive listing of North Carolina's life science industry New search
| Company Title | Company Description | City | |
|---|---|---|---|
| Accord Healthcare Inc. |
Accord Healthcare is the marketing subsidiary of Intas Pharmaceuticals, an India-based company that focuses on manufacturing generic pharmaceuticals and biosimilars for the global market. |
Durham | |
| Aegis Surgical Ltd. |
AEGIS is developing a less invasive access system that facilitates percutaneous transaortic transcatheter aortic valve replacement (pTAo-TAVR). |
Durham | |
| Affinergy LLC |
Affinergy develops peptide-based technologies, including diagnostic products, research tools and therapeutic drug monitoring products for use by clinicians and researchers. |
Morrisville | |
| Allwell Medical Corp. |
Allwell Medical manufactures interventional cardiology accessories including inflation devices, coronary control injection sets, balloons and catheters. |
Raleigh | |
| APIE-Therapeutics Inc. |
APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies. |
Cary | |
| AskBio |
Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. |
Research Triangle Park | |
| Baebies Inc. |
Baebies develops and commercializes products and services based on digital microfluidics and other technology that ensure early disease detection and comprehensive diagnosis for children. |
Durham | |
| Basking Biosciences Inc. |
Basking Biosciences is developing a reversible anti-thrombotic therapeutic to treat ischemic stroke. |
Research Triangle Park | |
| CardioEphEx LLC |
CardioEphEx develops therapeutics for cardiovascular disease and heart failure. The company's research focuses on cardioprotection by targeting the Ephrin/Eph receptor signaling pathway in the heart. |
Bahama | |
| CardioPharma Inc. |
CardioPharma develops combinatorial products to treat cardiovascular disease. |
Wilmington | |
| Catalyst Medicine LLC |
Catalyst Medicine designs, develops and commercializes Class 1 and Class 2 medical devices in the areas of neurology, orthopedics, cardiology and plastic surgery. |
Durham | |
| Cathtek Inc. |
Cathtek develops and manufactures catheters and related accessories. |
Winston-Salem | |
| Charles River Laboratories (Morrisville) |
Charles River Laboratories' Oncology Center of Excellence provides in vivo and in vitro oncology and immuno-oncology research services. |
Morrisville | |
| Chiesi USA Inc. |
Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A, develops and commercializes products in the therapeutic areas of rare disease, respiratory, cardiovascular, neonatology and cystic fibrosis. |
Cary | |
| Clinipace |
Clinipace provides full global CRO service to pharmaceutical and biotechnology companies, working across all major therapeutic areas including oncology, gastroenterology and women's health and rare disease. |
Morrisville | |
| CMP Pharma Inc. |
CMP develops, manufactures and commercializes niche oral liquid medications that address the needs of patients with difficulty swallowing solid dosage forms. |
Farmville | |
| Contego Medical LLC |
Contego Medical develops embolic protection devices for cardiovascular and peripheral vascular procedures, designed to simplify catheter-based procedures. |
Raleigh | |
| Grifols |
Grifols manufactures and markets plasma-derived medicines to treat chronic and acute conditions in the therapeutic areas of immunology, pulmonology, hematology, thrombolytics and neurology. |
Research Triangle Park | |
| Harmony Development Group |
Harmony Development Group is developing a passive intra-ventricular cardiac assist device that can slow down, stop and even reverse the cascade of heart failure dysfunction. |
Cornelius | |
| Humacyte Inc. |
Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. |
Durham | |
| InnAVasc Medical Inc. |
InnAVasc Medical designs and develops products for vascular access. The company's first technology is an arteriovenous graft (AVG) modification that facilitates graft access and safety in hemodialysis. |
Durham | |
| Kowa Research Institute Inc. |
Kowa Research Institute, a division of Kowa Company Ltd., develops therapeutic drugs for the treatment of cardio-metabolic diseases such as diabetes and atherosclerosis, pain and sensory organ disorders. |
Morrisville | |
| Liquidia Technologies Inc. |
Liquidia Technologies develops and commercializes human therapeutics for the treatment of pulmonary arterial hypertension and post-operative pain using its proprietary particle engineering technology. |
Morrisville | |
| MD Scientific LLC |
MD Scientific developed the EndoTool Glucose Management System and is currently developing a drug to prevent kidney and heart injury from iodinated contrast agents. |
Charlotte | |
| Micell Technologies Inc. |
Micell Technologies develops combination-product therapies for interventional cardiology. Micell markets MiStent, a drug-eluting stent, in Europe and certain other regions. |
Durham | |
| Milestone Pharmaceuticals USA Inc. |
Milestone Pharmaceuticals is developing an investigational new drug intended to provide rapid-onset and short-acting treatment of paroxysmal supraventricular tachycardia (PSVT) episodes and other episodic conditions. |
Charlotte | |
| Momentum Research Inc. |
Momentum Research manages and directs phase one through four clinical research projects and specializes in cardiovascular clinical trials management. |
Durham | |
| NeuroTronik Inc. |
NeuroTronik develops medical technology for the treatment of acute heart failure syndrome. |
Durham | |
| Nocturnal Product Development LLC |
Nocturnal Product Development provides contract design and development services for Class II and Class III medical devices. The company is also developing an ablation catheter that enables real-time visualization of ablated cardiac tissue. |
Durham | |
| NuPulseCV |
NuPulseCV is developing an implantable cardiovascular left ventricular assist device to treat people suffering from congestive heart failure. |
Raleigh | |
| PETNET Solutions Inc. (Winston-Salem) |
PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. |
Winston-Salem | |
| PETNET Solutions Inc., A Siemens Healthineers Company |
PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. |
Durham | |
| Phoenix Cardiac Devices Inc. |
Phoenix Cardiac Devices is designing and developing a cardiac device to treat functional mitral valve regurgitation. |
Cary | |
| QuatroBio LLC |
QuatroBio provides oversight and strategic direction to several closely held drug development companies. |
Morrisville | |
| SonoVascular Inc. |
SonoVascular is developing a thrombolysis device for the treatment of blood clots related to deep vein thrombosis, pulmonary embolism and peripheral arterial occlusions. |
Chapel Hill | |
| SunTech Medical Inc. |
SunTech Medical manufactures non-invasive blood pressure monitoring products and technology. |
Morrisville | |
| Tenax Therapeutics Inc. |
Tenax Therapeutics develops and commercializes pharmaceutical products for the critical care market. |
Morrisville | |
| Tryton Medical Inc. |
Tryton Medical develops and sells stent systems for the treatment of coronary artery bifurcation lesions. |
Durham | |
| United Therapeutics Corp. |
United Therapeutics develops and commercializes products to treat cardiopulmonary diseases, infectious diseases and cancer. |
Research Triangle Park | |
| Vascular BioSciences Inc. |
Vascular BioSciences is a biopharmaceutical company developing solutions for difficult-to-treat cardiovascular and inflammatory diseases. |
Durham | |
| Velo Bio LLC |
Velo Bio is developing an orphan drug for the treatment of severe preeclampsia in pregnant women. |
Morrisville | |
| Veloxis Pharmaceuticals Inc. |
Veloxis Pharmaceuticals is focused on the commercialization of ENVARSUS XR (tacrolimus extended-release tablets) based upon the company’s patented delivery technology, MeltDose. |
Cary | |
| Worldwide Clinical Trials Inc. |
Worldwide Clinical Trials provides phase one through phase four drug development services to the pharmaceutical and biotechnology industries. |
Morrisville | |
| X-in8 Biologicals Corp. |
X-in8 Biologicals develops technologies to prevent and treat ischemia reperfusion injury in the context of organ transplant, myocardial infarction and stroke. |
Chapel Hill | |
| Xollent Biotech Inc. |
Xollent Biotech is developing a therapeutic to treat cardiovascular disease based on exosome-secreting cells. |
Cary |